You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 11, November 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Off-Center Fold
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Diagnosis
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

Facial Erythema and Onychoschizia—Diagnosis

Arch Dermatol. 2005;141:1457-1462.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Diagnosis: Biotinidase deficiency.

MICROSCOPIC FINDINGS AND CLINICAL COURSE

The hematoxylin-eosin–stained punch biopsy specimen revealed mild acanthosis and hyperkeratosis, with a predominance of parakeratosis and mild perivascular infiltration of the upper dermis. Biotinidase activity was reduced to 50% and 26% (reference value, 8.4 nmol/min per milliliter) in the patient’s father and mother, respectively. Carboxylase activity was determined in a sample of the patient’s lymphocytes, revealing a significant reduction of propionyl-CoA [coenzyme A] carboxylase, {beta}-methylcrotonyl-CoA carboxylase, and pyruvate carboxylase to 26%, 36%, and 54%, respectively, of the levels seen in a normal unrelated control sample. Quantitative serum amino acid values were normal, and a urinary organic acid screen revealed mildly elevated concentrations of {beta}-methylcrotonylglycine and methylcitrate. The results of the rest of the laboratory studies, including complete blood cell count, differential cell count, standard chemistry panel, and liver function tests, were normal.

Biotinidase deficiency was diagnosed, and biotin therapy (dosage, 15 mg/d for 7 days and then tapered to 10 . . . [Full Text of this Article]

DISCUSSION


RELATED ARTICLE

Facial Erythema and Onychoschizia—Quiz Case
Juan Redondo-Mateo and Alfonso Urbon-Artero
Arch Dermatol. 2005;141(11):1457-1462.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.